Xconomy Boston

Mzinga Obtains $32,500,000 New Financing Round

  • Feed Type
  • Date
    3/3/2008
  • Company Name
    Mzinga
  • Mailing Address
    154 Middlesex Turnpike Burlington, ME 01803
  • Company Description
    Mzinga is the leading provider of business social media solutions to drive growth, innovation, and learning. Its combination of highly scalable technology, rich domain expertise, and moderation services enables businesses to harness the collective intelligence of employees, customers, and partners to achieve tangible business results. Marketing, customer service, and human resources professionals deploy Mzinga’s “pervasive community” solutions to achieve higher revenues, lower costs, and greater workplace satisfaction.
  • Website
    http://www.mzinga.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Mzinga plans to use this new funding to accelerate product development in response to increased demand, expand into new market segments, and increase sales and marketing investments. In support of these goals, a portion of the proceeds is being used to finance Mzinga’s recent acquisition of Prospero Technologies, a Massachusetts-based social media provider with a strong client base in the media, entertainment, and publishing sectors.
  • M&A Terms
  • Venture Investor
    W Capital Partners
  • Venture Investor
    BlueCrest Capital Finance LP
  • Venture Investor
    GE Pension Plan

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.